Pre-analytical guidelines for blood and CSF Biomarkers 2025: Recommendations from the NACC ADRC Biofluid Biomarker Best Practices Workgroup

Relation of blood-based inflammation conditional networks to key immune health status and Alzheimer’s biomarkers in aging adults

Large-scale CSF and plasma proteomics reveal immune dysregulation, synaptic impairment, and extracellular matrix alterations in neurodegeneration

Mucin-binding protein shuttles enable delivery of brain-targeted therapeutics

Plasma phosphorylated tau 217 detects amyloid-β in neuronal synuclein disease

Multivariate patterns of plasma biomarkers predict region-specific Alzheimer’s pathology and cognitive decline across independent cohorts

CSF proteomic profiling with amyloid and tau pathology identifies distinctive sex-specific alteration of multiple proteins involved in Alzheimer’s disease